Exact Sciences Cor (EXAS)
44.85 -0.74 (-1.62%) 10:50 ET [NASDAQ]
44.73 x 100 45.03 x 4
Realtime by (Cboe BZX)
44.73 x 100 45.03 x 4
Realtime 45.40 -0.19 (-0.42%) 09:11 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | EXAS | QGEN | RGEN | ||
| Company | Exact Sciences Cor | Qiagen N.V. | Repligen Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 45.80 | 42.50 | 135.15 | ||
| High | 45.93 | 42.59 | 143.40 | ||
| Low | 45.01 | 42.40 | 132.46 | ||
| Last | 44.79 | 42.51 | 134.46 | ||
| Change | -0.80 | +0.04 | -9.17 | ||
| % Change | -1.75% | +0.09% | -6.38% | ||
| Volume | 231,536 | 163,128 | 446,928 | ||
| 20-Day Average Volume | 2,713,707 | 1,592,674 | 925,147 | ||
| Previous Close | 45.59 | 42.47 | 143.63 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 43.89 | 41.10 | 128.91 | ||
| 20-Day Raw Stochastic | 83.26% | 76.87% | 73.47% | ||
| 20-Day Relative Strength | 49.86% | 55.58% | 49.70% | ||
| Weighted Alpha | -24.74 | -4.54 | -16.84 | ||
| Today's Opinion | 88% Sell | 40% Sell | 64% Sell | ||
| Previous Opinion | 88% Sell | 40% Sell | 48% Sell | ||
| Last Month's Opinion | 100% Sell | 88% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.81% since 04/22/25 | +0.50% since 04/22/25 | -1.58% since 04/22/25 | ||
| Low | 43.98 on 04/23/25 | 41.82 on 04/25/25 | 133.25 on 04/29/25 | ||
| High | 46.47 on 04/28/25 | 43.13 on 04/24/25 | 148.94 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | +3.96% since 03/28/25 | +6.78% since 03/28/25 | +2.50% since 03/28/25 | ||
| Low | 39.97 on 04/08/25 | 38.13 on 04/04/25 | 102.96 on 04/07/25 | ||
| High | 46.48 on 04/07/25 | 43.88 on 04/15/25 | 148.94 on 04/23/25 | ||
| 3-Month | |||||
| %Chg | -17.31% since 01/29/25 | -2.79% since 01/29/25 | -19.28% since 01/29/25 | ||
| Low | 39.97 on 04/08/25 | 37.63 on 03/04/25 | 102.96 on 04/07/25 | ||
| High | 57.23 on 01/31/25 | 45.05 on 01/31/25 | 177.17 on 01/30/25 | ||
| 6-Month | |||||
| %Chg | -34.82% since 10/29/24 | -1.10% since 10/29/24 | +1.39% since 10/29/24 | ||
| Low | 39.97 on 04/08/25 | 37.63 on 03/04/25 | 102.96 on 04/07/25 | ||
| High | 72.83 on 11/05/24 | 49.30 on 01/22/25 | 182.52 on 01/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,468,571 | 9,440,699 | 8,064,680 | ||
| Shares Outstanding, K | 185,755 | 222,291 | 56,149 | ||
| Annual Sales | 2,758,870,000 | 1,978,210,000 | 634,440,000 | ||
| Annual Net Income | -1,028,860,000 | 83,590,000 | -25,510,000 | ||
| Last Quarter Sales | 713,420,000 | 521,200,000 | 174,150,000 | ||
| Last Quarter Net Income | -864,590,000 | 88,320,000 | -30,280,000 | ||
| 60-Month Beta | 1.14 | 0.62 | 1.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 02/19/25 | 0.61 on 02/05/25 | 0.44 on 02/20/25 | ||
| Latest Earnings Date | 05/01/25 | 05/07/25 | 04/29/25 | ||
| Most Recent Dividend | N/A | 0.027 on 12/27/02 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.82 | 97.80 | ||